Related Experiment Video
Updated: Mar 20, 2026

A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms
Published on: September 16, 2022
Use of DOOR and Win-Ratio Analysis in a Secondary Evaluation of a Histoplasmosis Clinical Trial
Tarsila Vieceli1, Biyue Dai2, Diego R Falci3
1Post-graduation Program in Pathology, Federal University of Health Sciences of Porto Alegre, Porto Alegre, Brazil.
Abstract:
Hierarchical composite end points may better reflect patient outcomes, rather than mortality alone. We applied DOOR and Win-Ratio analyses to a phase II trial comparing single high-dose vs standard liposomal amphotericin B for HIV-associated histoplasmosis. No clear differences were observed, supporting feasibility and informing design of future phase III trials.
More Related Videos
Related Concept Videos
Hazard Ratio
For example, in a clinical trial...
Comparing the Survival Analysis of Two or More Groups
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Odds Ratio
Receiver Operating Characteristic Plot

